Fundraising Fox
Pathoquest
Paris, FR · Founded 2010 · 60 employees on LinkedIn · 2 known investors
Find your way into Pathoquest
Sign up to find every way you can get introduced to Pathoquest
- Your email: who you already know at Pathoquest, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pathoquest team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics. The company was acquired by Charles River Labs to expand its end-to-end biologics testing portfolio.
Founders & leadership
Pathoquest was founded in 2010 by Marc Eloit.
Investors · 2
.jpeg){kind=logo}
Frequently asked questions
- What does Pathoquest do?
- PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics. The company was acquired by Charles River Labs to expand its end-to-end biologics testing portfolio.
- Who founded Pathoquest?
- Pathoquest was founded by Marc Eloit in 2010.
- Who are Pathoquest's investors?
- Pathoquest's investors include Kurma Partners, Verve Ventures.
- Where is Pathoquest headquartered?
- Pathoquest is headquartered in Paris, FR.